Hepatitis B virus DNA during pregnancy and post partum: Aspects on vertical transmission

Scandinavian Journal of Infectious Diseases

Volumn 35, Issue 11-12, 2003, Pages 814-819

  Söderström, Ann ^a   Norkrans, Gunnar ^a   Lindh, Magnus ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AUNATIV; ENGERIX; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; MAJOR CLINICAL STUDY; NEWBORN; PREGNANCY; PUERPERIUM; RETROSPECTIVE STUDY; VERTICAL TRANSMISSION; VIREMIA; VIRUS CARRIER;

EID: 0348229370     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310016547     Document Type: Article

References (26)

1. Lin HH, Chen PJ, Chen DS, Sung JL, Yang KH, Young YC, et al. Post-partum subsidence of hepatitis B viral replication in HBeAg- positive carrier mothers. J Med Virol 1989; 29(1): 1-6.
2. Wejstal R, Widell A, Norkrans G. HCV-RNA levels increase during pregnancy in women with chronic hepatitis C. Scand J Infect Dis 1998; 30(2): 111-3.
3. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292(15): 771-4.
4. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2(8359): 1099-102.
5. Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 1(8635): 406-10.
6. del Canho R, Grosheide PM, Schalm SW, de Vries RR, Heijtink RA. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994; 20(4): 483-6.
7. Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994; 44(2): 144-51.
8. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90(5 Pt 1): 1268-73.
9. del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15(15): 1624-30.
10. Lee SD, Lo KJ, Wu JC, Tsai YT, Wang JY, Ting LP, Tong MJ. Prevention of maternal-infant hepatitis B virus transmission by immunisation: the role of serum hepatitis B virus DNA. Hepatology 1986; 6(3): 369-73.
11. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998; 27(1): 100-6.
12. Almog Y, Klein A, Adler R, Laub O, Tur-Kaspa R. Oestrogen suppresses hepatitis B virus expression in male athymic mice transplanted with HBV transfected Hep G-2 cells. Antiviral Res 1992; 19(4): 285-93.
13. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2(8663): 588-91.
14. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, et al. Hepatitis B virus with mutations in the core promoter for an e antigen- negative phenotype in carriers with antibody to e antigen. J Virol 1994; 68(12): 8102-10.
15. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 1990; 87(17): 6599-603.
16. Bahn A, Hilbert K, Martine U, Westedt J, von Weizsacker F, Wirth S. Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants. J Med Virol 1995; 47(4): 336-41.
17. Hawkins AE, Gilson RJ, Beath SV, Boxall EH, Kelly DA, Tedder RS, Weller IV. Novel application of a point mutation assay: evidence for transmission of hepatitis B viruses with precore mutations and their detection in infants with fulminant hepatitis B. J Med Virol 1994; 44(1): 13-21.
18. Terazawa S, Kojima M, Yamanaka T, Yotsumoto S, Okamoto H, Tsuda F, et al. Hepatitis B virus mutants with precore-region defects in 2 babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res 1991; 29(1): 5-9.
19. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30(5): 1312-7.
20. Ngui SL, O'Connell S, Eglin RP, Heptonstall J, Teo CG. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis 1997; 176(5): 1360-5.
21. van Nunen AB, de Man RA, Heijtink RA, Niesters HG, Schalm SW. Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. J Hepatol 2000; 32(6): 1040-1.
22. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang ZL, Ng HT. Role of Caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1988; 2(8615): 833-4.
23. Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl) 2002; 115(10): 1510-2.
24. Grosheide PM, del Canho R, Voogd M, Heijtink RA, Schalm SW. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunisation with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B. Vaccine 1994; 12(12): 1059-63.
25. Sangfelt P, Reichard O, Lidman K, von Sydow M, Forsgren M. Prevention of hepatitis B by immunisation of the newborn infant: a long- term follow-up study in Stockholm, Sweden. Scand J Infect Dis 1995; 27(1): 3-7.
26. Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 1999; 6(2): 135-9.